Upgrade to SI Premium - Free Trial

UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)

May 28, 2026 10:09 AM
UBS analyst Michael Yee reiterated a Buy rating and $70.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments